(Reuters) -Swiss-American eye-care group Alcon on Tuesday cut its 2025 net sales outlook, saying it expects the impact of U.S. tariffs to persist through the remainder of the year.
Alcon, which makes nearly half of its revenue in the U.S., lowered its projected net sales range to $10.3 to $10.4 billion from $10.4 to $10.5 billion forecasted in May.
It now forecasts a full-year gross tariff impact around $100 million but expects to offset that through operational changes and foreign exchange movements.
The U.S. tariff rate of 39% on goods from Switzerland is higher than nearly any other Western trading partner.
In 2024 46% of Alcon’s net sales were made in the U.S.
The Swiss-American group posted a 4% rise in its second-quarter sales to $2.58 billion, missing analysts’ average forecast of $2.63 billion, according to LSEG data. It said demand for its surgical products was relatively weak in the first half.
Alcon shares were down 8.25% in Julius Baer pre-market indications as at 0620 GMT.
(Reporting by Simon Ferdinand Eibach and Bartosz Dabrowski in Gdansk; Editing by Matt Scuffham)
